SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Satellos Reports Third Quarter 2026 Financial Results and Highlights Company Progress

TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage company developing potentially life-improving medicines to treat degenerative muscle diseases, today announced financial results for the third quarter ended September 30, 2026. The compan…

MSCL

Related stories